{"name":"George Medicines PTY Limited","slug":"george-medicines-pty-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPWE5PeDl6VGpTS2dfMDZUcVk1STN4LUhpdkJwS19NX0RCamlac2NzbGw5N3hkdTg1Q2xUd1VHLWZTQjdpLXlIdXhycFIycnMwSWxxRXlVcDNMblQtTEVnRjlSXzdvNHVzUThNN3VBMExMRnB0QmlhUmRWSXh0Y1RiZnhka3ZNTmtHekcydVJoSXNGS3EzM2RBNExyRVhuMTh0SzdFc1JGdzBKRVNTNVRnamlTQkYxQXlQOTczUzl3aEZ2WDZ1WUJfZllBb0diSWZmMDJBUFpsdzNIak9UcWRNREYzdll2SjJWT2ZORFBxQkdSWk1tRGww?oc=5","date":"2026-03-03","type":"deal","source":"Citeline News & Insights","summary":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","headline":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOSHpHeE1qNXdFMGIza1pJVDdHcjI1ekJDVC1JQ3RWSmx6VVhFai01a2tEQnRjWllkSlJGMEM3SUY5N191eVNRTFQta3N3TEw2dHJsMFMyZDRxRWJyNHRfWXVmLVFqNHl5WHJldzFQa0xYUmpqZXluWGx5blFUSC1JN3M0eXd1Vy1leERCLXFGelRhQlNrUXR0TDVQUWotZ09qOHVwOEs3WnhMRHk3OVF6S0hfaHJ0a0E?oc=5","date":"2026-03-03","type":"pipeline","source":"The Motley Fool Australia","summary":"Why Capstone Copper, Life360, Neuren, and St George Mining shares are falling today - The Motley Fool Australia","headline":"Why Capstone Copper, Life360, Neuren, and St George Mining shares are falling today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOclVyWVVaZWd5OHdNNHc1SnVnVjZaYkx1TWhQdlBIdEt2eF8tbDFpVUVUanhEZEVzaUdxLVhoVEVWZGkyMEhaZjFTVExDUV9SZ1lwQUlobTVkcDB4cEhqUGpIWGFTb2tMQkUybHFEUTR5M1ItX21SRTBHYy0yQWVZSGo3NlAwTG1nVE13MG8xcFhhZHhyZHA1RUlvcXN4bVpDZElvd2k1LTIwT1k?oc=5","date":"2025-11-26","type":"trial","source":"BioWorld News","summary":"Merck’s Keytruda and Welireg power October’s phase III oncology wins - BioWorld News","headline":"Merck’s Keytruda and Welireg power October’s phase III oncology wins","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBMT0RpZ3ZuVmhVNU0tN01idlVLNzlyNWZtWUtadHFJTVhHX2FLRHFyb2lQM25sNlB6LWxOZjRnMVBKbkZCcEpKN1RmLXdQZDJ4VzNEdUdLTnE5R29feHcxekt4UDNkdm5wckE?oc=5","date":"2025-10-18","type":"pipeline","source":"businessplus.ie","summary":"Microneedle technology opens up possibilities for pharma startup ArrayPatch - businessplus.ie","headline":"Microneedle technology opens up possibilities for pharma startup ArrayPatch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNTTNMZldhcTEwbV81QzVCRi1GOVdELU1JVGVlU1lXSnluYVN2aTJGLXlPRm56Ujk5cWJzMU9qM1FMNi1WUTNOZGFyVUh1VS01aHJQQmMwMXRoNjhUZ2hsXzNRMXhtUDZCWEdfNVczZm1yeHZ4RG9PQ0lNNTlUNjc5ZTJuNG1jSnlPbW0yeG1oS20yU2RHMGRMakhpbnN5bjBoQWFaWko1Y3F6MEM5MTdUYm9IM0JERUh1VlhZaEZSUXdJa0YxRktRelRjN2xEb1hvUUdoUlpkRml1YmVVS2hkbTJmOXNXSm1SUndRWkdFWTlwemF2and0eDlJaVhPeWZIaGRMUUFXOEQ5MWNjVjlnU1RPUm1EYXRkdmFMUmdGRGstaHA5YXRkZl8tdmhJSTNiNmRoWWZveDFVY1RKMklaNjBsbWxEX1VXY1h0cGhwVjZQMGR5cWc?oc=5","date":"2025-07-21","type":"pipeline","source":"GlobeNewswire","summary":"George Medicines signs exclusive licensing agreement with - GlobeNewswire","headline":"George Medicines signs exclusive licensing agreement with","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-15","type":"deal","source":"simplywall.st","summary":"Insider Stock Buying Reaches US$201.4m On Mesoblast - simplywall.st","headline":"Insider Stock Buying Reaches US$201.4m On Mesoblast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOOGtzUHNmN0hwalJEWHY5a0xxT0d6ajNSWU9DZTQ0Y2p0Z2piSExIN0pYTmNMUS14YWx2WmpUVVA0ekVyejlKc2diRHdSd3VFTW5MbUlTN3FKSzc4STJFenA5R1RLbDY2MUhSLVZrUjkyUXRPUXR5VXUzR2wxOVBjOWNaVmpRVVVjLTZhdEJHSjNfSmJwVFpPM0p1aFVhWU9yWmNvaXRFOWd1aUpY?oc=5","date":"2025-06-09","type":"pipeline","source":"Medscape Reference","summary":"Addressing Partial Treatment Response in MDD Patients - Medscape Reference","headline":"Addressing Partial Treatment Response in MDD Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNNk1rNUU1OUVuV2NUamNNZXRGa1NuVXVmSHpnVXZmNVd0RmhlLUJmNzFrUFQ5UUxobnZObk5TaVkyTG9hY1lUanJsZE1mTDVQNEhkdkZFX25Lb3BVWTZlblNTM0xhaTRxRHBRdXREc2xCai01VXhGb2QtNzl2ZVJiMDdXQjY?oc=5","date":"2024-09-02","type":"trial","source":"Clinical Trials Arena","summary":"George Medicines reports data from two Phase III hypertension treatment trials - Clinical Trials Arena","headline":"George Medicines reports data from two Phase III hypertension treatment trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9SMEl2R09LRHJYQUpMRzlZVTZCNzBMb0dBb2QtdkxfdG82QzhEbHAtUTh3SjFrbUdGLW03YW5RclUxaFFRbG44VXFIVWJTMUhSeHZ4TXVpbVBmZ2RzWlFB?oc=5","date":"2024-09-02","type":"trial","source":"StudyFinds","summary":"Groundbreaking 3-in-1 pill may replace standard blood pressure drugs - StudyFinds","headline":"Groundbreaking 3-in-1 pill may replace standard blood pressure drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TcWZTV1hpdU11dDdrNEN2MVpOejNUdU85cjlfbF9ad2hrUk41REhPanV3T0x3b05CR1pGYWFDcmd5SWNvVlJhWVBUNVF2cDd4eWY0ci1VbTVjelc2RnFv?oc=5","date":"2024-03-07","type":"trial","source":"nature.com","summary":"Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial | Molecular Psychiatry - natur","headline":"Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9lODI5LW80YXB4cWxYUU5fbjBhOG1zYkVpUS1KNl8yTHpaR0dnU052TUZfWXBjaGpGX0xmbC15TmF1aTVSM0EyWG1BYWhSa19waXdqWkk0QmtVUEJXT056cS1oNlFvdw?oc=5","date":"2022-11-09","type":"pipeline","source":"MedPage Today","summary":"Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertension - MedPage Today","headline":"Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNXzAzeGRMYk9aLXJZSkVVRFFPRmlvaTdMeWdfWGM5VVUxTXdUMWtOQjRsZEFNX3pUTTlxRFlQREZjbEJUN25QRWVGUVZMYXFESExLT0k3TlhOZ0Zkc1g3aE1ESV83SnJKVW9zQkRybHR6b0ZYa0tXTldOVUlDVmdVMVBUTU5wcHF3TkRCYWh6cXd5SjdfNHh2dWZCbGJaY2tIRGZWc2RQcVh1alctQnEzTFczNGw0anFqZm1CY2pVaHJBN1hMYldmSnJyWkM?oc=5","date":"2022-11-07","type":"pipeline","source":"Healio","summary":"‘Quad therapy’ strategy may improve BP control vs. angiotensin receptor blocker monotherapy - Healio","headline":"‘Quad therapy’ strategy may improve BP control vs. angiotensin receptor blocker monotherapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}